TITRE LOREM IPSUM
TITRE LOREM IPSUM
QuickTime™ et undécompresseur TIFF (non compressé)ont requis pour visionner cette image.
QuickTime™ et undécompresseur TIFF (non compressé)ont requis pour visionner cette image.
QuickTime™ et undécompresseur TIFF (non compressé
sont requis pour visionner cette imageQuickTime™ et un
décompresseur TIFF (non compressé)sont requis pour visionner cette image.
QuickTime™ et undécompresseur TIFF (non compressé)
sont requis pour visionner cette image.
QuickTime™ et undécompresseur TIFF (non compressé
sont requis pour visionner cette image
QuickTime™ et undécompresseur TIFF (non compressé)
sont requis pour visionner cette image.
QuickTime™ et undécompresseur TIFF (non compressé)
sont requis pour visionner cette image.
TITRE LOREM IPSUM
TITRE LOREM IPSUM
TITRE LOREM IPSUM
RETENTISSEMENT DE LA SURDITÉ
Chez l’enfant,
difficultés d’acquisition du langage parlé risque d’échec scolaire important choix professionnel restreint
Chez l’adulte devenu sourd,
isolement, solitude perte du lien social syndrome dépressif réactionnel
TITRE LOREM IPSUM
1 enfant sur 700 est atteint d’une forme de surdité sévère ou profonde à la naissance
1 enfant sur 1000 deviendra sourd, sévère ou profond, avant l’âge adulte
2,3% de la population entre 60 et 70 ans souffrent d’une atteinte auditive sévère
40% des individus au-delà de 70 ans, ont une perte auditive qui gène les échanges conversationnels
SURDITÉ ET MALENTENDANCE
TITRE LOREM IPSUM
TITRE LOREM IPSUM
TITRE LOREM IPSUM
TITRE LOREM IPSUM
TITRE LOREM IPSUM
1916
10
6
TITRE LOREM IPSUM
TITRE LOREM IPSUM
TITRE LOREM IPSUM
TITRE LOREM IPSUM
75 weeks for 70 students
TITRE LOREM IPSUM
TITRE LOREM IPSUM
TITRE LOREM IPSUM
TITRE LOREM IPSUM
TITRE LOREM IPSUM
TITRE LOREM IPSUM
EuroHear
Coordinator: Pr. Christine Petit, Institut Pasteur, Professor at the Collège de France - Inserm U 587- University ParisVI
Co-coordinator: Pr. Karen B. Avraham, Tel Aviv University
TITRE LOREM IPSUM
context of the project
More than 40 millions of people
are hearing impaired, in the EU (10%). Deafness is the most frequent sensory defect. It may occur at any age with any
degree of severity.
-More than 1 child out of 1000 is severely or profoundly deaf at birth. In these children, speech acquisition and learning to read are considerably hindered.
-Over 65, a third of the population is suffering from hearing loss impeding conversation. This results in major impediment to daily life and threatens personal autonomy and finally in social isolation and often in depression.
HEARING IS THE SENSE OF THE COMMUNICATIONHEARING IS THE SENSE OF THE COMMUNICATION
-There is no treatment (only protheses).
-Cost is over 90 billion € annually in EU.
TITRE LOREM IPSUM
context of the project
When considering the “Disability –adjusted – life – year (DALY). hearing loss ranks 13th in 2002
and will rank 9th in 2030. It is the sum of two components: Years Lived with disability+Years of life
lost= DALY. Meaning that the years lost due to disability caused by late onset form of deafness will
become more and more prevalent regarding the other disorders in the coming years.
Mathers & Loncar PLOS Med 2006
TITRE LOREM IPSUM
Objectives of the project
EuroHear has three closely related objectives:
-To identify the genes causative for sensorineural hearing impairment: early and late onset forms
-To understand the mechanisms underlying normal and impaired hearing
-To develop tools to prevent and to cure of hearing impairment
TITRE LOREM IPSUM
Acoustic trauma →
ATP →
Ca2+ connection
A unique situation in which genetics and understanding how an organ functions, goes hand in hand.
Methodologies
cochlea
TITRE LOREM IPSUM
What is the value of the european dimension?
- Searching for deafness genes in humans and mouse (Enu mutagenesis programs)for early and late onset forms of deafness, in parallel, is the most efficient way to access to the human deafness genes.Mouse and human cochlea are highly similar.
QuickTime™ et undécompresseur TIFF (non compressé)
sont requis pour visionner cette image.
- Pooling the ressources (DNA samples) a sine qua non condition to find some human deafness genes (late onset form, presbycusis).
-To get an integrated view of how the hearing organ works, physicians, human and mouse geneticists, cell biologists, biochemists, electrophysiologists, physicists and theoricians have to work together.On its own, none of the european countries, has such a potential.
TITRE LOREM IPSUM
major achievements (1)
Finding of genes causative for hearing impairment in mouse and
humans
• We have identified 15 new loci for deafness• We have discovered 12 new genes for deafness
4 deafness genes causative isolated (non-syndromic) deafness. Among them, we identified the first gene causing a defect only in neurons of the central nervous system processing the auditory information but not affecting the sensory hearing organ, the cochlea.
8 genes mutated in syndromic deafness.
Altogether, within the FP5&6 programs, identification of half of the known genes for deafness.
TITRE LOREM IPSUM
major achievements (2)
Understanding of the mechanisms involved in normal
and impaired hearing
Shaker-1 mutant
From Jax Lab
QuickTime™ et undécompresseur codec YUV420
sont requis pour visionner cette image.
from human deafness to mouse model
multidisciplinaryapproaches
TITRE LOREM IPSUM
major achievements (2)
Understanding of the mechanisms involved in normal and impaired hearing
We elucidated the way in which the deafness genes we had discovered are leading to deafness i.e -the vessel barrier within the cochlea may be disrupted in some of deafness, -the total lack of neurotransmission (a multidisciplinary european effort).
We began understanding how the compartments of the auditory sensory cells are operating and which molecules are implicated.
TITRE LOREM IPSUM
major achievements (3)
Drug screening and novel methods for stimulating the regeneration or the replacement of sensory cells are being actively explored.
Some of our findings have already had positive impacts for patients: -molecular diagnosis for the new genes has been developed, -clinical description for each form of deafness including its prognosis is well on its way, -epidemiological data are in the process of being generated, -the controversy regarding the possible benefit of cochlear implants in some forms of deafness has been partially solved.
On the basis of our findings of the functional connections between several deafness genes, we are now in a position to identify possible targets for therapies, common to several deafness forms.
TITRE LOREM IPSUM
Training and meetings
• Theoretical training : 1 week every year for more than 30 european students
– 2006: Physiology of the cochlea– 2007: Imaging: cell and tissue
Practical training: 23 weeks for 20 students in 2006
• Meetings:– « The structure and operation of the Hair Bundle »,
April 2007: 130 scientists from 16 different countries– « Hearing and Seeing: European research to fight
deafness and blindness », July 2007: 170 participants expected
TITRE LOREM IPSUM
Conclusions
• We believe that EuroHear is on the right track
• Two major issues: - Identification of the genes causative for late onset forms of
deafness, presbycusis (objectives: diagnostic, prevention and curing)
- To make sure to go on pooling our efforts and expertise in the future.. With their multidisciplinary approaches, EuroHear Partners should indeed have the leadership to stand upcoming challenges both in basic and medical terms.
TITRE LOREM IPSUM
acknowledgements
The identification of genes is made possible by the
active involvement of hearing-impaired patients and their
families
Surdité et audition : des gènes pour comprendre
Christine PETIT
TITRE LOREM IPSUM
TITRE LOREM IPSUM
Construction d’un espace plurisciplinaire européen de recherche sur l’audition et la surdité : réalisations, perspectives
Pour la traiter:
Surdité et audition : des gènes pour comprendre
TITRE LOREM IPSUM
TITRE LOREM IPSUM
Surdité et audition : des gènes pour comprendre
• Christine PETIT
TITRE LOREM IPSUM